His primary scientific interests are in Internal medicine, Cardiology, Atrial fibrillation, Catheter ablation and Surgery. His research related to Tachycardia, Electrocardiography, Ejection fraction, Myocardial infarction and Ventricular tachycardia might be considered part of Cardiology. His Atrial fibrillation research incorporates themes from Stroke, Radiofrequency ablation, Intensive care medicine and Catheter.
His Catheter ablation research entails a greater understanding of Ablation. His Ablation research includes elements of Nuclear medicine and Hazard ratio. Karl-Heinz Kuck frequently studies issues relating to Radiology and Surgery.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Catheter ablation, Atrial fibrillation and Surgery. His work in the fields of Ablation, Sinus rhythm and Heart failure overlaps with other areas such as In patient. His Ablation research is multidisciplinary, relying on both Fluoroscopy, Nuclear medicine and Left atrial.
Tachycardia, Ventricular tachycardia, Myocardial infarction, Ejection fraction and Stenosis are the primary areas of interest in his Cardiology study. He interconnects Heart disease, Intensive care medicine and Catheter in the investigation of issues within Catheter ablation. Karl-Heinz Kuck combines subjects such as Stroke, Radiofrequency ablation and Radiology with his study of Atrial fibrillation.
His primary areas of study are Internal medicine, Cardiology, Atrial fibrillation, Catheter ablation and Ablation. Karl-Heinz Kuck integrates Internal medicine with In patient in his research. Karl-Heinz Kuck regularly links together related areas like Hazard ratio in his Cardiology studies.
His study in Atrial fibrillation is interdisciplinary in nature, drawing from both Radiofrequency ablation and Surgery, Balloon. The concepts of his Catheter ablation study are interwoven with issues in Stroke, Clinical endpoint, Heart disease and Tamponade. His work in Ablation addresses issues such as Complication, which are connected to fields such as Incidence.
Internal medicine, Cardiology, Catheter ablation, Atrial fibrillation and Pulmonary vein are his primary areas of study. He merges Internal medicine with In patient in his study. His study looks at the relationship between Cardiology and fields such as Cohort, as well as how they intersect with chemical problems.
His Catheter ablation research is multidisciplinary, incorporating perspectives in Ventricular tachycardia and Randomized controlled trial. His Atrial fibrillation research is multidisciplinary, incorporating elements of Radiofrequency ablation, Surgery and Confidence interval. His Pulmonary vein study combines topics from a wide range of disciplines, such as Bare-metal stent, Isolation, Tachycardia, Major complication and Left atrial.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada.
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada.
Journal of Interventional Cardiac Electrophysiology (2012)
2017 HRS / EHRA / ECAS / APHRS / SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Hugh Calkins;Gerhard Hindricks;Riccardo Cappato;Young Hoon Kim.
Heart Rhythm (2017)
HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA)
Hugh Calkins;Josep Brugada;Douglas L. Packer;Riccardo Cappato.
Heart Rhythm (2007)
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
Silvia G. Priori;Carina Blomström-Lundqvist.
Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).
Karl Heinz Kuck;Riccardo Cappato;Jürgen Siebels;Rudolf Rüppel.
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy
Christian Templin;Jelena R. Ghadri;Johanna Diekmann;L. Christian Napp.
The New England Journal of Medicine (2015)
HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation
Hugh Calkins;Josep Brugada;Douglas L. Packer;Ricardo Cappato.
Prophylactic Use of an Implantable Cardioverter-Defibrillator After Acute Myocardial Infarction
Stefan H. Hohnloser;Karl Heinz Kuck;Paul Dorian;Robin S. Roberts.
The New England Journal of Medicine (2004)
Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial
S Hohnloser;K.H Kuck;J Lilienthal.
The Lancet (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: